Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Anergis logo

Anergis

Recent Finacing

Series A

Recent Raise

$19.5M

Anergis is a clinical-stage biopharmaceutical company in Epalinges, Switzerland, developing immunotherapies for allergic diseases, advancing lead candidate AllerT into a large Phase II multicenter trial and expanding preclinical R&D.

Founded 2001
Vaud, Switzerland
11-50
Private
anergis.ch

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Medical
Personal Health

Recent Investors

Sunstone Capital logo
Esperante logo
Vinci Capital/Renaissance PME logo
BioMedPartners logo
I

Financials

$19.5M

Total Raised

1

Funding round

5

Investors